BioSphere Medical, Inc. to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference

ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD) – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – announced today that Martin Joyce, its executive vice president and chief financial officer, is scheduled to present at the 22nd Annual Roth Capital Partners OC Growth Stock Conference on Monday, March 15, 2010 at 3:30 p.m. Pacific Time. The conference will be held at the Ritz Carton, Laguna Niguel in Dana Point, Calif.

Back to news